Capricor Therapeutics IncNASDAQ:CAPR
- LAST PRICE3.0350
- TODAY'S CHANGE (%)0.0950 (3.2313%)
- Bid / Lots3.0200/ 1
- Ask / Lots3.0400/ 4
- Open / Previous Close2.9700 / 2.9400
- Day Range
- 52 Week Range
- Volume39,367
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CAPR |
|---|---|---|
| 09:32 ET | 2404 | 2.945 |
| 09:35 ET | 100 | 2.97 |
| 09:53 ET | 1280 | 2.98 |
| 09:55 ET | 100 | 2.985 |
| 10:00 ET | 230 | 3.004 |
| 10:02 ET | 8393 | 3 |
| 10:04 ET | 1250 | 3.0755 |
| 10:06 ET | 1000 | 3 |
| 10:15 ET | 476 | 2.9489 |
| 10:18 ET | 706 | 2.99 |
| 10:31 ET | 1000 | 3 |
| 10:33 ET | 967 | 3.01 |
| 10:36 ET | 2298 | 3.05 |
| 10:44 ET | 900 | 3.045 |
| 10:54 ET | 130 | 3.05 |
| 11:02 ET | 100 | 3.05 |
| 11:12 ET | 800 | 3.05 |
| 11:14 ET | 2240 | 3.04 |
| 11:16 ET | 600 | 3.02 |
| 11:27 ET | 2000 | 3.03 |
| 11:36 ET | 100 | 2.995 |
| 11:39 ET | 355 | 2.9749 |
| 11:43 ET | 100 | 2.995 |
| 11:45 ET | 2524 | 2.98 |
| 12:01 ET | 300 | 3.005 |
| 12:06 ET | 142 | 3.005 |
| 12:28 ET | 100 | 3.02 |
| 12:33 ET | 100 | 3.005 |
| 12:37 ET | 100 | 3.0176 |
| 12:48 ET | 265 | 3.005 |
| 12:50 ET | 344 | 3.01 |
| 12:51 ET | 100 | 3 |
| 12:55 ET | 300 | 2.995 |
| 01:02 ET | 200 | 2.995 |
| 01:06 ET | 400 | 2.995 |
| 01:15 ET | 600 | 3.005 |
| 01:18 ET | 100 | 3.005 |
| 01:22 ET | 100 | 3.01 |
| 01:26 ET | 100 | 3.02 |
| 01:29 ET | 100 | 3.01 |
| 01:36 ET | 300 | 3.01 |
| 01:45 ET | 200 | 3.005 |
| 01:47 ET | 200 | 3.01 |
| 01:51 ET | 400 | 3.02 |
| 01:58 ET | 100 | 3.05 |
| 02:00 ET | 200 | 3.035 |
| 02:07 ET | 100 | 3.02 |
| 02:12 ET | 100 | 3.035 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Capricor Therapeutics Inc | 71.0M | -3.7x | --- |
Applied Genetic Technologies Corp | 71.6M | -1.0x | --- |
Axcella Health Inc | 71.2M | -1.1x | --- |
Rezolute Inc | 71.5M | -1.5x | --- |
Marker Therapeutics Inc | 69.8M | -1.3x | --- |
Lantern Pharma Inc. | 71.5M | -5.2x | --- |
Company Information
Capricor Therapeutics, Inc. is a biotechnology company. The Company is focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of diseases. It consists of cell therapy program, including CAP-1002 with Duchenne muscular dystrophy program and CAP-1002 with COVID-19 (SARS-CoV-2) program. It also includes exosomes program, such as exosome-based vaccines, exosome-based therapeutics and CDC-Derived Exosomes (CAP-2003). Duchenne muscular dystrophy program has completed HOPE-2, a Phase II clinical trial in the United States with its product candidate.CAP-1002 is a cardiac cell derived therapy used to treat patients with late-stage Duchenne muscular dystrophy. The Company has received the United States Food and Drug Administration (FDA) acceptance of its investigational new drug (IND) application for a clinical study of CAP-1002 in patients with severe or critical COVID-19.
Contact Information
- Headquarters
- 8840 Wilshire Blvd Fl 2BEVERLY HILLS, CA, United States 90211-2606
- Phone
- 310-358-3200
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Frank Litvack
- President, Chief Executive Officer, Director
- Linda Marban
- Chief Financial Officer, Principal Accounting Officer
- Anthony Bergmann
- Executive Vice President, General Counsel
- Karen Krasney
- Director
- Karimah Es Sabar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $71.0M |
|---|---|
Revenue (TTM) | $302.7K |
Shares Outstanding | 24.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 6.00 |
EPS | $-0.81 |
Book Value | $1.37 |
P/E Ratio | -3.7x |
Price/Sales (TTM) | 234.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,085.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
